Mercom Insider

GSK Pharma to Procure Power from CleanMax’s 4.95 MW Solar Project

The company will acquire a 26% stake in Clean Max Galapagos

November 10, 2025

/ Meghana Prasad
/ Markets & Policy, Solar
thumbnail

Follow Mercom India on WhatsApp for exclusive updates on clean energy news and insights


GlaxoSmithKline Pharmaceuticals (GSK) has announced it will source power from a 4.95 MW solar project of Clean Max Galapagos, a special purpose vehicle (SPV) of CleanMax, in Maharashtra.

MERCOM Insider

Where clean energy's most influential leaders get their intelligence

Exclusive reporting, market intelligence, and insider access that shapes billion-dollar decisions in renewable energy and clean technology.

Already have an account? Sign In

Register for free

thumbnail

Meghana Prasad

More articles from Meghana Prasad.
AcquisitionGlaxoSmithKline PharmaceuticalsMaharashtraSolarStake
PREVALL POSTSNEXT

RELATED POSTS

Get the most relevant India solar and clean energy news.

RECENT POSTS